Health Care: Drugs

Valeant Pharmaceuticals International Inc (VRX: NYSE)

$15.46 n/a | n/a%
12/09/16 - 04:00 PM ET
Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) -287.80M 879.40M -863.60M -116.00M
Operating Gains/Losses 25.40M -123.90M 75.20M 30.90M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -625.90M -572.40M -300.60M -175.80M
(Increase) Decrease in Inventories -276.00M -192.80M -122.70M -80.30M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 170.30M 246.10M -76.50M -8.40M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items 519.20M 285.40M 619.30M 292.00M
Net Cash From Continuing Operations 2.20B 2.29B 1.04B 656.60M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 2.20B 2.29B 1.04B 656.60M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 66.70M 53.20M 35.20M 624.80M
Purchases of Property, Plant & Equipment -303.30M -470.60M -184.90M -181.10M
Acquisitions -15.44B 389.70M -5.21B -3.39B
Purchases of Short-Term Investments -49.30M -72.00M -18.20M -7.20M
Other Cash from Investing Activities -31.50M 0.00 0.00 -8.90M
Cash Provided by Financing Activities
Net Cash From Investing Activities -15.58B -99.70M -5.38B -2.97B
Issuance of Debt 17.82B 1.65B 8.41B 6.04B
Cash Used for Financing Activities
Issuance of Capital Stock 30.20M 17.20M 10.00M 23.00M
Repayment of Long-Term Debt -5.19B -3.92B -6.40B -2.57B
Repurchase of Capital Stock -72.40M 0.00 -55.60M -280.70M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 1.08B -193.50M 2.06B -159.70M
Net Cash From Financing Activities 13.68B -2.44B 4.03B 3.06B
Effect of Exchange Rate Changes -30.10M -29.00M -5.20M 3.80M
Net Change in Cash & Cash Equivalents 274.70M -277.70M -315.80M 752.00M

Portfolios with VRX

Latest VRX Headlines from TheStreet

More Financial News for VRX

Press Releases for VRX

See All Press Releases

Partner Headlines for VRX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter